Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark
Vought Rising Trailer Debut Fuels Franchise Momentum Following The Boys Finale
Wall Street Opens Higher as AI Optimism and Mideast Truce Hopes Boost Sentiment
HDFC Bank Shares Dip After Report Reveals 45 Crore Payment Probe CEO Reappointment Likely Unaffected
How Rising Treasury Yields May Influence Consumer Finances and Market Sentiment
Indian Equity Markets Edge Higher as Financial Stocks Lead Indecisive RangeBound Movement Persists
OLPX Q1 2026 Earnings EPS Beats Estimates by 7094
Smurfit WestRock Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
AN Q1 2026 Earnings EPS Beats Estimates by 1 but Stock Edges Lower
VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline
GWW Q1 2026 Earnings Earnings per Share Surpass Estimates by Nearly 13
SPMA Q1 2026 Earnings Preferred Share Earnings Fall Short of Estimates
TotalEnergies TTE Slides 17 as Energy Sector Faces Headwinds Key Support and Resistance Levels in Focus
Security National Financial SNFCA Sees Minor Decline Holding Above Key Support at 888
EQV Ventures Acquisition Corp II EVAC Stability at 1017 as SPAC Awaits Catalyst
Mineralys Therapeutics MLYS Holds Steady Near Resistance as Volume Remains Muted
EPower Inc EPOW Slides 28 as Shares Test Key Support at 066
Ferrari Shares Dip After First Fully Electric Vehicle Launch
RDI Q3 2025 Earnings EPS Misses Estimates Amid Operational Challenges
Baldwin Insurance Group BWIN Advances 242 Nears Key 2044 Resistance
GEOS Q1 2026 Earnings Adjusted Loss of 086 Per Share Stock Declines
Fluor Corporation FLR Q1 2026 Earnings EPS Falls Short as Shares Edge Higher
GCI Liberty Inc Series C GLIBK Q1 2026 Earnings EPS Misses Estimates by 6389 Stock Slides
SRE Q1 2026 Earnings Slight EPS Miss as Utility Performance Holds Steady
BNS Q1 2026 Earnings EPS Beats Estimates by Nearly 4 as Bank Delivers Solid Results
Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected
CGTX Q1 2026 Earnings Narrower Loss Exceeds Estimates as PreRevenue Biotech Advances Pipeline